Trials / Completed
CompletedNCT00864266
Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer
Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer : a Prospective Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- European Lung Cancer Working Party · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary aim of the study is to identify a predictive molecular signature for response to chemotherapy, according to WHO criteria, in patients with non-small cell lung cancer by studying the transcriptome (miRNAs and mRNAs) and the single nucleotide polymorphism (SNPs) by using high throughput techniques.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chemotherapy | Standard cisplatin-based chemotherapy in agreement with the ELCWP guidelines (available on the website www.elcwp.org) |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2020-06-01
- Completion
- 2020-06-01
- First posted
- 2009-03-18
- Last updated
- 2020-06-26
Locations
6 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00864266. Inclusion in this directory is not an endorsement.